Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 800 of 3173 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/18/19
End: 03/30/21
Due: 03/30/22
Phase: N/A
Priority: Normal
Start: 10/07/22
End: 06/23/23
Due: 06/23/24
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 11/17/23
End: 02/19/26
Due: 02/19/27
Phase: N/A
Priority: Normal
Start: 08/22/23
End: 11/14/26
Due: 11/14/27
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 06/30/26
Due: 06/30/27
The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 07/31/07
Due: 07/31/08
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 10/31/08
Due: 10/31/09
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 01/23/18
End: 11/28/22
Due: 11/28/23
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 09/26/18
End: 01/19/19
Due: 01/19/20
Phase: N/A
Priority: Normal
Start: 09/27/11
End: 06/09/14
Due: 06/09/15
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 06/30/10
Due: 06/30/11